CITRUPRESS IV Trademark

Trademark Overview


On Thursday, February 16, 2012, a trademark application was filed for CITRUPRESS IV with the United States Patent and Trademark Office. The USPTO has given the CITRUPRESS IV trademark a serial number of 85544923. The federal status of this trademark filing is CANCELLED - SECTION 8 as of Friday, April 19, 2019. This trademark is owned by Asklepion Pharmaceuticals, LLC. The CITRUPRESS IV trademark is filed in the Pharmaceutical Products category with the following description:

Pharmaceuticals for the prevention of pulmonary hypertension in pediatric patients undergoing surgery for the correction of congenital heart defects
citrupress iv

General Information


Serial Number85544923
Word MarkCITRUPRESS IV
Filing DateThursday, February 16, 2012
Status710 - CANCELLED - SECTION 8
Status DateFriday, April 19, 2019
Registration Number4209840
Registration DateTuesday, September 18, 2012
Mark Drawing4000 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateTuesday, July 3, 2012

Trademark Statements


Disclaimer with Predetermined Text"IV"
Goods and ServicesPharmaceuticals for the prevention of pulmonary hypertension in pediatric patients undergoing surgery for the correction of congenital heart defects
Pseudo MarkCITRUPRESS FOUR; CITRUPRESS INTRAVENOUS

Classification Information


International Class005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes006, 018, 044, 046, 051, 052
Class Status Code2 - Sec. 8 - Entire Registration
Class Status DateFriday, April 19, 2019
Primary Code005
First Use Anywhere DateThursday, February 14, 2008
First Use In Commerce DateThursday, December 22, 2011

Trademark Owner History


Party NameAsklepion Pharmaceuticals, LLC
Party Type30 - Original Registrant
Legal Entity Type16 - Limited Liability Company
AddressBaltimore, MD 21202

Party NameAsklepion Pharmaceuticals, LLC
Party Type20 - Owner at Publication
Legal Entity Type16 - Limited Liability Company
AddressBaltimore, MD 21202

Party NameAsklepion Pharmaceuticals, LLC
Party Type10 - Original Applicant
Legal Entity Type16 - Limited Liability Company
AddressBaltimore, MD 21202

Trademark Events


Event DateEvent Description
Friday, April 19, 2019CANCELLED SEC. 8 (6-YR)
Thursday, December 21, 2017TEAS CHANGE OF CORRESPONDENCE RECEIVED
Monday, September 18, 2017COURTESY REMINDER - SEC. 8 (6-YR) E-MAILED
Monday, July 27, 2015TEAS CHANGE OF CORRESPONDENCE RECEIVED
Friday, January 11, 2013TEAS CHANGE OF CORRESPONDENCE RECEIVED
Monday, December 17, 2012TEAS CHANGE OF CORRESPONDENCE RECEIVED
Tuesday, September 18, 2012REGISTERED-PRINCIPAL REGISTER
Tuesday, July 3, 2012OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Tuesday, July 3, 2012PUBLISHED FOR OPPOSITION
Wednesday, June 13, 2012NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Wednesday, May 30, 2012APPROVED FOR PUB - PRINCIPAL REGISTER
Tuesday, May 29, 2012ASSIGNED TO EXAMINER
Saturday, February 25, 2012NOTICE OF PSEUDO MARK MAILED
Friday, February 24, 2012NEW APPLICATION OFFICE SUPPLIED DATA ENTERED IN TRAM
Monday, February 20, 2012NEW APPLICATION ENTERED IN TRAM